Soltanzadeh Zarandi Sina, Loeb Charles A, Barham David W, Miller Jake A, Schneider Douglas, Hammad Muhammed A Moukhtar, Yafi Faysal A
Department of Urology, University of California Irvine, Orange, CA, USA.
Transl Androl Urol. 2023 Feb 28;12(2):217-227. doi: 10.21037/tau-22-486. Epub 2023 Feb 6.
Information regarding the Medicaid coverage of artificial urinary sphincter (AUS) and male suburethral slings (MS) placement in the United States (US) is not readily available. In this manuscript, we seek to elucidate the state-by-state Medicaid coverage of these two procedures in the US.
State Medicaid websites were utilized to access publicly available physician fee schedules for the calendar year 2020. Fee schedules were searched for current procedural terminology (CPT) codes. CPT codes representing insertion of tandem cuff, insertion of AUS, removal of AUS, removal and replacement AUS, sling operation for correction of male stress urinary incontinence (SUI), and removal or revision of sling for male SUI were utilized. Data were recorded by the procedure for each device, including the coverage status and physician fees.
Of the 50 US states analyzed, 49 publish publicly accessible physician fee schedules. All 49 of these states reported coverage for removal with and without revision of the AUS, and 48 states reported coverage for insertion of an AUS, and insertion of a tandem cuff. The median reimbursement for each AUS related procedure was $624.00 ($181.84-$10,960.90) for tandem cuff, $665.54 ($199.89-$11,949.86) for AUS insertion, $528.03 ($146.90-$1,893.12) for AUS removal, and $630.29 ($208.55-$11,586.74) for AUS revision. All 49 states reported coverage for placement of MS, and 48 states reported coverage for removal or revision of MS. The median reimbursement was $652.57 ($198.00-$5,237.35) for MS placement and $554.47 ($104.27-$2,288.93) for MS revision.
AUS and MS procedures in the Medicaid population are covered by nearly all states. Therefore, surgical treatment of SUI may be offered to Medicaid patients in most states without reimbursement concerns.
在美国,关于医疗补助计划(Medicaid)对人工尿道括约肌(AUS)植入和男性尿道下吊带(MS)植入的覆盖情况的信息并不容易获取。在本论文中,我们试图阐明美国各州医疗补助计划对这两种手术的覆盖情况。
利用各州医疗补助计划网站获取2020年日历年公开可用的医生收费表。在收费表中搜索当前程序术语(CPT)代码。使用代表串联袖带插入、AUS植入、AUS移除、AUS移除并更换、男性压力性尿失禁(SUI)矫正的吊带手术以及男性SUI吊带移除或修复的CPT代码。按每个器械的手术记录数据,包括覆盖状态和医生费用。
在分析的50个美国州中,49个州公布了可公开获取的医生收费表。这49个州均报告了AUS移除(无论是否修订)的覆盖情况,48个州报告了AUS植入和串联袖带插入的覆盖情况。每个与AUS相关手术的报销中位数为:串联袖带624.00美元(181.84美元 - 10,960.90美元),AUS植入665.54美元(199.89美元 - 11,949.86美元),AUS移除528.03美元(146.90美元 - 1,893.12美元),AUS修订630.29美元(208.55美元 - 11,586.74美元)。所有49个州均报告了MS植入的覆盖情况,48个州报告了MS移除或修订的覆盖情况。MS植入的报销中位数为652.57美元(198.00美元 - 5,237.35美元),MS修订为554.47美元(104.27美元 - 2,288.93美元)。
医疗补助计划人群中的AUS和MS手术几乎在所有州都有覆盖。因此,在大多数州,无需担心报销问题,可为医疗补助计划患者提供SUI的手术治疗。